Anesiva Announces Filing Of New Drug Application For Zingo(TM) To Reduce Pain Associated With Needle Insertion Procedures In Children

... Anesiva, Inc. (Nasdaq: ANSV) announced today that the company has filed a New Drug Application (NDA) with the FDA for marketing clearance of Zingo(TM) to treat the pain associated with venous access procedures in children. As part of the company's continued development of Zingo, Anesiva expects to begin a follow-on clinical trial in adults in early 2007. [click link for full article] ...